Ainos (NASDAQ: AIMD) — Perfil da empresa, notícias e dados financeiros
Ainos is a biopharmaceutical company developing innovative health solutions to enhance patient outcomes globally.
Ainos
Ainos (NASDAQ:AIMD) focuses on developing and commercializing innovative health solutions that aim to dramatically improve patient outcomes. From cutting-edge biomedical devices to advanced pharmaceuticals, Ainos's projects span a wide range of technologies and applications designed to tackle today's most challenging health issues. The company's objectives are deeply rooted in leveraging scientific research to bring novel treatments and diagnostics to the market, ultimately enhancing the quality of life for patients worldwide. Through strategic partnerships and a dedicated team of experts, Ainos is committed to pushing the boundaries of medicine and healthcare.
Resumo
Operações
Produtos e/ou serviços de Ainos
- An innovative health monitoring platform leveraging AI for real-time data analysis and health insights.
- A blockchain-based solution for secure and transparent medical data exchange.
- A mobile application focused on fertility tracking, offering personalized health insights.
- An AI-powered diagnostic tool designed to improve accuracy and efficiency in disease detection.
- A cloud-based platform for healthcare professionals, facilitating patient management and collaboration.
- Custom software development services for healthcare organizations, aiming to enhance operational efficiency and patient care.
equipe executiva do Ainos
- Chun-Hsien TsaiCEO, President & Chairman of the Board
- Hsin-Liang LeeChief Financial Officer
- Chih-Heng LuDirector of Corporate Developoment
Principais indicadores financeiros
Resultados divulgados pela Ainos, em USD.
- Cap. de mercado
- 6 mi
- Receita (TTM)
- 13,6 mil
- P/L
- —
- LPA (diluído, TTM)
- -2.5
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 124,2 mil | -14 mi | -14,8 mi | |
| 20,7 mil | -13,8 mi | -14,9 mi | |
| 122,1 mil | -13,2 mi | -13,8 mi | |
| 3,5 mi | -14 mi | -14 mi |